PMC:7239011 / 1977-2266 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"31","span":{"begin":102,"end":106},"obj":"Disease"},{"id":"32","span":{"begin":119,"end":156},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D010146"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D018908"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"GlobalAll age groupsMales 1.5 times more affectedRespiratory or gastrointestinal\u003c 6 weeksParesthesia, pain followed by weakness of limbsLess commonAreflexic quadreparesisCommonCommonLess common25%Ocular nervesUncommonUncommonAIDP--IVIG, PlasmapherisisGood, persistent disability in 20%-30%"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":102,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012531"}],"text":"GlobalAll age groupsMales 1.5 times more affectedRespiratory or gastrointestinal\u003c 6 weeksParesthesia, pain followed by weakness of limbsLess commonAreflexic quadreparesisCommonCommonLess common25%Ocular nervesUncommonUncommonAIDP--IVIG, PlasmapherisisGood, persistent disability in 20%-30%"}